Cover Image
市場調查報告書

Acumen Pharmaceuticals Inc. :產品平台分析

Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 276024
出版日期 內容資訊 英文 22 Pages
訂單完成後即時交付
價格
Back to Top
Acumen Pharmaceuticals Inc. :產品平台分析 Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2015
出版日期: 2015年03月11日 內容資訊: 英文 22 Pages
簡介

Acumen Pharmaceuticals Inc.是開發並提供針對老年癡呆症的緩解疾病性治療方法及診斷法的生物科技企業。該公司同時也致力於開發老年癡呆症的免疫療法,也正在研發透過檢測人體的髓液之診斷方法。

本報告提供Acumen Pharmaceuticals Inc. 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃相關等資訊。

Acumen Pharmaceuticals, Inc.的基本資料

  • Acumen Pharmaceuticals, Inc.概要
  • 主要資訊
  • 企業資料

Acumen Pharmaceuticals, Inc.:R&D概要 ▼主要治療範圍

Acumen Pharmaceuticals, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Acumen Pharmaceuticals, Inc.:開發中產品概況

  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Acumen Pharmaceuticals, Inc.:藥物簡介

  • ACU-193
  • ACU-193 Back-up
  • Drugs to Inhibit ADDL Receptor for Alzheimers Disease
  • Vaccine to Target ADDL for Alzheimers Disease

Acumen Pharmaceuticals, Inc.:開發平台分析

  • 標的別
  • 各分子類型
  • 各作用機制

Acumen Pharmaceuticals, Inc.:最近的開發平台趨勢

Acumen Pharmaceuticals, Inc.:暫停中的計劃

Acumen Pharmaceuticals, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06846CDB

Summary

Global Markets Direct's, 'Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Acumen Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Acumen Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Acumen Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Acumen Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Acumen Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Acumen Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Acumen Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Acumen Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Acumen Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Acumen Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Acumen Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Acumen Pharmaceuticals, Inc. Snapshot
    • Acumen Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Acumen Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Acumen Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Acumen Pharmaceuticals, Inc. - Pipeline Products Glance
    • Acumen Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Acumen Pharmaceuticals, Inc. - Drug Profiles
    • ACU-193
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ACU-193 Back-up
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drugs to Inhibit ADDL Receptor for Alzheimer's Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine to Target ADDL for Alzheimer's Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Acumen Pharmaceuticals, Inc. - Pipeline Analysis
    • Acumen Pharmaceuticals, Inc. - Pipeline Products by Target
    • Acumen Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Acumen Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Acumen Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Acumen Pharmaceuticals, Inc. - Dormant Projects
  • Acumen Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Acumen Pharmaceuticals, Inc., Key Information
  • Acumen Pharmaceuticals, Inc., Key Facts
  • Acumen Pharmaceuticals, Inc. - Pipeline by Indication, 2015
  • Acumen Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Acumen Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Acumen Pharmaceuticals, Inc. - Preclinical, 2015
  • Acumen Pharmaceuticals, Inc. - Pipeline by Target, 2015
  • Acumen Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
  • Acumen Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Acumen Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
  • Acumen Pharmaceuticals, Inc. - Dormant Developmental Projects,2015

List of Figures

  • Acumen Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top